These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
210 related items for PubMed ID: 9438096
1. Serum C-reactive protein as a marker for infection and inflammation in regular dialysis patients. McIntyre C, Harper I, Macdougall IC, Raine AE, Williams A, Baker LR. Clin Nephrol; 1997 Dec; 48(6):371-4. PubMed ID: 9438096 [Abstract] [Full Text] [Related]
2. Raised plasma total sialic acid levels are markers of cardiovascular disease in renal dialysis patients. Afzali B, Bakri RS, Bharma-Ariza P, Lumb PJ, Dalton N, Turner NC, Wierzbicki AS, Crook MA, Goldsmith DJ. J Nephrol; 2003 Dec; 16(4):540-5. PubMed ID: 14696756 [Abstract] [Full Text] [Related]
3. Peritoneal transport status influence on atherosclerosis/inflammation in CAPD patients. Sezer S, Tutal E, Arat Z, Akçay A, Celik H, Ozdemir FN, Haberal M. J Ren Nutr; 2005 Oct; 15(4):427-34. PubMed ID: 16198934 [Abstract] [Full Text] [Related]
4. Effect of an increase in C-reactive protein level during a hemodialysis session on mortality. Korevaar JC, van Manen JG, Dekker FW, de Waart DR, Boeschoten EW, Krediet RT, NECOSAD study group. J Am Soc Nephrol; 2004 Nov; 15(11):2916-22. PubMed ID: 15504945 [Abstract] [Full Text] [Related]
5. Relationship of pregnancy-associated plasma protein-a to renal function and dialysis modalities. Fialová L, Kalousová M, Soukupová J, Sulková S, Merta M, Jelínková E, Horejsí M, Srámek P, Malbohan I, Mikulíková L, Tesar V, Zima T. Kidney Blood Press Res; 2004 Nov; 27(2):88-95. PubMed ID: 14739577 [Abstract] [Full Text] [Related]
6. Positive correlation of CRP and fibrinogen levels as cardiovascular risk factors in early stage of continuous ambulatory peritoneal dialysis patients. Tekin IO, Pocan B, Borazan A, Ucar E, Kuvandik G, Ilikhan S, Demircan N, Ozer C, Kadayifci S. Ren Fail; 2008 Nov; 30(2):219-25. PubMed ID: 18300125 [Abstract] [Full Text] [Related]
7. The effects of peritoneal dialysis and hemodialysis on serum tumor necrosis factor-alpha, interleukin-6, interleukin-10 and C-reactive-protein levels. Borazan A, Ustün H, Ustundag Y, Aydemir S, Bayraktaroglu T, Sert M, Yilmaz A. Mediators Inflamm; 2004 Jun; 13(3):201-4. PubMed ID: 15223612 [Abstract] [Full Text] [Related]
8. The effects of hemodialysis and peritoneal dialysis on serum homocysteine and C-reactive protein levels. Borazan A, Aydemir S, Sert M, Yilmaz A. Mediators Inflamm; 2004 Dec; 13(5-6):361-4. PubMed ID: 15770053 [Abstract] [Full Text] [Related]
9. Comorbidity and acute clinical events as determinants of C-reactive protein variation in hemodialysis patients: implications for patient survival. Snaedal S, Heimbürger O, Qureshi AR, Danielsson A, Wikström B, Fellström B, Fehrman-Ekholm I, Carrero JJ, Alvestrand A, Stenvinkel P, Bárány P. Am J Kidney Dis; 2009 Jun; 53(6):1024-33. PubMed ID: 19394732 [Abstract] [Full Text] [Related]
11. Ceruloplasmin and acute phase protein levels are associated with cardiovascular disease in chronic dialysis patients. Panichi V, Taccola D, Rizza GM, Consani C, Migliori M, Filippi C, Paoletti S, Sidoti A, Borracelli D, Panicucci E, Giovannini L. J Nephrol; 2004 Jun; 17(5):715-20. PubMed ID: 15593040 [Abstract] [Full Text] [Related]
12. IL-18 is involved in vascular injury in end-stage renal disease patients. Porazko T, Kúzniar J, Kusztal M, Kúzniar TJ, Weyde W, Kuriata-Kordek M, Klinger M. Nephrol Dial Transplant; 2009 Feb; 24(2):589-96. PubMed ID: 18775894 [Abstract] [Full Text] [Related]
13. [C-reactive protein in diagnosis of complications in renal insufficiency and failure]. Erben J, Panácek V, Procházka J, Stambergová H. Vnitr Lek; 2004 Jul; 50(7):497-502. PubMed ID: 15323255 [Abstract] [Full Text] [Related]
14. Successful kidney transplantation does not reverse the coagulopathy in patients with chronic renal failure on either hemo or peritoneal dialysis. Ballow A, Gader AM, Huraib S, Mitwalli A, Al-Suleimani F, Al-Wakeel J. Saudi J Kidney Dis Transpl; 2007 Jun; 18(2):177-85. PubMed ID: 17496391 [Abstract] [Full Text] [Related]
15. Measurement of circulating troponin Ic enhances the prognostic value of C-reactive protein in haemodialysis patients. Boulier A, Jaussent I, Terrier N, Maurice F, Rivory JP, Chalabi L, Boularan AM, Delcourt C, Dupuy AM, Canaud B, Cristol JP. Nephrol Dial Transplant; 2004 Sep; 19(9):2313-8. PubMed ID: 15252159 [Abstract] [Full Text] [Related]
16. Influence of oral vitamin E therapy on micro-inflammation and cardiovascular disease markers in chronic hemodialysis patients. Hodkova M, Dusilova-Sulkova S, Kalousova M, Soukupova J, Zima T, Mikova D, Malbohan IM, Bartunkova J. Ren Fail; 2006 Sep; 28(5):395-9. PubMed ID: 16825088 [Abstract] [Full Text] [Related]
17. Association between C-reactive protein and clinical outcomes in peritoneal dialysis patients. Avram MM, Fein PA, Paluch MM, Schloth T, Chattopadhyay J. Adv Perit Dial; 2005 Sep; 21():154-8. PubMed ID: 16686309 [Abstract] [Full Text] [Related]
18. The prognostic impact of fluctuating levels of C-reactive protein in Brazilian haemodialysis patients: a prospective study. Nascimento MM, Pecoits-Filho R, Qureshi AR, Hayashi SY, Manfro RC, Pachaly MA, Renner L, Stenvinkel P, Lindholm B, Riella MC. Nephrol Dial Transplant; 2004 Nov; 19(11):2803-9. PubMed ID: 15496560 [Abstract] [Full Text] [Related]
19. Persistent elevation of C-reactive protein and ischemic heart disease in patients with continuous ambulatory peritoneal dialysis. Kim SB, Min WK, Lee SK, Park JS, Hong CD, Yang WS. Am J Kidney Dis; 2002 Feb; 39(2):342-6. PubMed ID: 11840375 [Abstract] [Full Text] [Related]
20. [Inflammatory status in patients with end-stage renal disease: role of monocyte activation]. Liang M, Wang L, Hou FF, Liu J, Liu ZQ, Tian JW. Di Yi Jun Yi Da Xue Xue Bao; 2003 Aug; 23(8):781-4. PubMed ID: 12919896 [Abstract] [Full Text] [Related] Page: [Next] [New Search]